A Study to Assess Adverse Events and Change in Disease Activity of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation in Adult Participants
NCT05452070
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
171
Enrollment
INDUSTRY
Sponsor class
Conditions
Mid Face Volume Deficit
Interventions
DEVICE:
HArmonyCa Lidocaine Injectable Gel
Sponsor
Allergan